Alignment Healthcare sells $330 million convertible notes, repays $215 million loan
Alignment Healthcare completed the sale of $330 million of 4.25% convertible senior notes due 2029 and reported net cash proceeds of approximately $321.05 million. The company used the proceeds to repay in full the term loans under its Oxford Loan Agreement, which had $215 million of principal outstanding, and the agreement was terminated. The notes can convert into common stock, so the financing changes the company's debt structure and could affect shareholders if conversion occurs.
Key points
- $330 million aggregate principal of 4.25% Convertible Senior Notes due 2029, issued under an indenture dated November 22, 2024, with U.S. Bank Trust Company, National Association, as trustee
- Net cash proceeds of approximately $321.05 million after fees, discounts and estimated expenses
- Oxford term loans, which carried interest at SOFR + 6.5%, were repaid in full on November 22, 2024, with $215 million outstanding as of that date, and all liens were released
- Notes were sold to institutional accredited and qualified institutional buyers in a private offering exempt from Securities Act registration
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 25, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.